Page last updated: 2024-12-08

azaphen

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

azaphen: antidepressant with a tricyclic structure may affect the autonomic nervous system; minor descriptor (77-85); on-line & Index Medicus search OXAZINES (77-85); RN given refers to (di-HCl); don't confuse with AZOPHEN, a brand name for ANTIPYRINE [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159976
MeSH IDM0262854

Synonyms (38)

Synonym
HY-A0022
azaphen hydrochloride
5h-pyridazino(3,4-b)(1,4)benzoxazine, 5-methyl-3-(4-methyl-1-piperazinyl)-, dihydrochloride
azaphen
5-methyl-3-(4-methyl-1-piperazinyl)-5h-pyridazino(3,4-b)(1,4)benzoxazine dihydrochloride
2-(4-methyl-1-piperazinyl)-10-methyl-3,4-diazaphenoxazindihydrochlorid [german]
azafen
24853-80-3
BCP9000351
mfb4td413u ,
2-(4-methyl-1-piperazinyl)-10-methyl-3,4-diazaphenoxazindihydrochlorid
unii-mfb4td413u
BCPP000369
azaphenonxazine 2hcl
CS-0632
AKOS022183357
pipofezin hydrochloride
pipofezine hydrochloride [who-dd]
11096-84-7
2-(4-methylpiperazinyl)-10-methyl-3,4-diazaphenoxazine dihydrochloride
pipofezine hydrochloride
10-methyl-3-(4-methyl-piperazin-1-yl)-10h-9-oxa-1,2,10-triaza-anthracene dihydrochloride
azaphenonxazine dihydrochloride
DTXSID10179554
2-(4-methyl-1-piperazinyl)-10-methyl-3,4-diazaphenoxazine dihydrochloride
J-015701
pipofezine hcl
azaphenoxazine 2hcl
azaphenonxazine
azafen;pipofezin hydrochloride;pipofezine hydrochloride
azaphen 2hcl
BCP27680
azafen;pipofezin;pipofezine;azaphenonxazine 2hcl
Q27283992
A919261
5-methyl-3-(4-methylpiperazin-1-yl)pyridazino[3,4-b][1,4]benzoxazine;dihydrochloride
AC-35766
E98653

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Tricyclic antidepressants, not influencing the P450 3A4 activity, are safe in combination with drugs of other groups used in the treatment of comorbid patients."( [Preclinical investigation of pharmaceuticals impact against cytochrome P450 activity and prognosis of substrate affinity as means for providing substrate therapy safety].
Baĭchorov, IKh; Fomin, EV; Shikh, EV; Sizova, ZhM, 2013
)
0.39

Compound-Compound Interactions

ExcerptReferenceRelevance
"Mucosal gastric damages in rats induced by intragastric ethanol introduction decreased considerably on the background of action of one of the antidepressants (asaphen, inkasan and OF-743) in combination with arginine."( [The antiulcer action of antidepressants. II. The effect of the antidepressants inkazan, azafen, and OF-743 in combination with arginine on ethanol-evoked damage to the gastric mucosa in rats].
Ashmarin, IP; Natsvlishvili, NA; Samonina, GE, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (30.00)18.7374
1990's4 (40.00)18.2507
2000's2 (20.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.90 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (15.38%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (84.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]